Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Altimmune Inc ALT

Healthcare Biotechnology
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The Company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). The Company has completed the MOMENTUM Phase II obesity trial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALT)

Altimmune Statement on the Passing of Dr. Stephen Harrison

GlobeNewswire 1 day ago

Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 27, 2024

Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024

GlobeNewswire March 20, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT

Accesswire March 9, 2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT

PR Newswire March 5, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT

Newsfile March 5, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT

PR Newswire March 3, 2024

ROSEN, A LEADING NATIONAL FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT

Newsfile March 2, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Altimmune, Inc. - ALT

Accesswire March 1, 2024
View More News ››

Opinion & Analysis (NDAQ:ALT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALT)

Racing to finnish

Up up up up
Nibinator - December 6, 2023

Can the President Overrule the FDA on Vaccines?

An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA  has shortened standard...
schoolofrock - October 7, 2020

no and no

NO CURE FOR CANCER since 1981 https://en.wikipedia.org/wiki/Terry_Fox_Run NO CURE FOR HIV https://www.hiv.gov/hiv-basics/hiv...
starman1975 - May 26, 2020

I can’t get over today’s volume!

Can someone explain to me how this stock went from 49.00 down to 1.70 in a year? They seem to have lots of cash on hand as well.
SeekAlpha81 - March 19, 2019

breakout alert for this one

it's going up big time,so glta shareholders.
coolfooldumbguy - March 19, 2019

RE:Well some News is out get on board

https://clinicaltrials.gov/ct2/show/NCT03760549?term=nasoVAX&rank=1
MrMikeTriumph - March 7, 2019
View more Bullboard ››

EasTower Wireless Inc

EasTower Wireless Inc

EasTower Wireless Inc is a U.S. provider of wireless communications infrastructure and related services.. The firm ...
View More »